|
|||||
|
|
Phase II trial of continuous low -dose temozolomide for patients with recurrent malignant glioma |
|
| Authors: | Omuro A;Chan TA;Abrey LE;Khasraw M;Reiner AS;Kaley TJ;Deangelis LM;Lassman AB;Nolan CP;Gavrilovic IT;Hormigo A;Salvant C;Heguy A;Kaufman A;Huse JT;Panageas KS;Hottinger AF;Mellinghoff I; |
| Institution: | Omuro A;Chan TA;Abrey LE;Khasraw M;Reiner AS;Kaley TJ;Deangelis LM;Lassman AB;Nolan CP;Gavrilovic IT;Hormigo A;Salvant C;Heguy A;Kaufman A;Huse JT;Panageas KS;Hottinger AF;Mellinghoff I;Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; |
| Abstract: | |
| Keywords: | |
| 本文献已被 CNKI 等数据库收录！ | |